IP Library Granted Patent US 10,253,357
Granted Patent B2
US 10,253,357 · App. 15/306,240 · Granted Apr 9, 2019

Colorimetric detection of nucleic acid amplification

Inventors: Debkishore Mitra (Berkeley, CA); Ivan Krastev Dimov (Union City, CA); John Robert Waldeisen (Berkeley, CA)
Assignee: DIASSESS INC.
C12Q1/6844C12Q1/6846
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,253,357
App. No.
15/306,240
Granted
Apr 9, 2019
Kind
B2
Abstract

Colorimetry is used to detect amplification reaction products. A sample is contacted with a reaction mix under conditions such that an amplification reaction occurs and produces an amplification reaction product if the sample contains a target nucleic acid template molecule. The reaction mix includes an enzyme for catalyzing the amplification reaction, and at least one halochromic agent. If the target nucleic acid template molecule is present, the amplification reaction changes the starting pH of the reaction mix to cause a detectable colorimetric change of the halochromic agent, thereby indicating the presence of the target nucleic acid. If the target nucleic acid template molecule is not present, the amplification reaction does not generate an adequate number of protons to sufficiently change the starting pH of the reaction mix to cause a detectable colorimetric change of the halochromic agent, thereby indicating that the amplification reaction product has not been produced.

Claims (52)

1. A method for colorimetric detection of a nucleic acid amplification reaction product in a sample, the method comprising:

contacting the sample with a reaction mix under conditions such that a nucleic acid amplification reaction occurs and produces a nucleic acid amplification reaction product if the sample contains a target nucleic acid template molecule, the reaction mix having a starting pH and comprising:

a buffer having a buffering capacity equivalent to Tris buffer at a concentration between 1.5 mM-19 mM in a solution having a starting pH of 8.0;

an enzyme for catalyzing the nucleic acid amplification reaction; and

a halochromic agent;

wherein if the target nucleic acid template molecule is present, the nucleic acid amplification reaction changes the starting pH of the reaction mix to cause a detectable colorimetric change of the halochromic agent, thereby indicating the presence of the target nucleic acid, and wherein if the target nucleic acid template molecule is not present, the nucleic acid amplification reaction does not generate an adequate number of protons to sufficiently change the starting pH of the reaction mix to cause a detectable colorimetric change of the halochromic agent, thereby indicating that the nucleic acid amplification reaction product has not been produced.

2. The method of claim 1 , wherein detection of the nucleic acid amplification reaction product is accelerated relative to a nucleic acid amplification reaction using a reaction mix without a halochromic agent.

3. The method of claim 2 , wherein the nucleic acid amplification reaction using a reaction mix without a halochromic agent comprises detection of nucleic acid amplification reaction product by fluorescent intercalating dyes, molecular beacons, hybridization probes, dye-based detection, UV-Vis, Agarose Gels or Lateral Flow Assay.

4. The method of claim 1 , wherein the colorimetric change of the reaction mix is detected throughout the performance of the nucleic acid amplification reaction.

5. The method of claim 1 , wherein the colorimetric change of the reaction mix is detected after the performance of the nucleic acid amplification reaction.

6. The method of claim 1 , wherein the detection of the colorimetric change of the reaction mix is associated with a digital indication of a presence of the nucleic acid amplification reaction product.

7. The method of claim 1 , wherein the colorimetric change of the reaction mix is detected by measuring fluorescence or absorbance of the reaction mix.

8. The method of claim 1 , wherein the colorimetric change of the reaction mix is detected by visual detection of the reaction mix.

9. The method of claim 1 , wherein the detection of the colorimetric change of the reaction mix indicates that an exponential phase or a plateau phase of the nucleic acid amplification reaction has been obtained.

10. The method of claim 1 , wherein the colorimetric change of the reaction mix is detected in less than 60 minutes from a starting time before the performance of the nucleic acid amplification reaction.

11. The method of claim 1 , wherein the nucleic acid amplification reaction is a thermocycled reaction.

12. The method of claim 1 , wherein the nucleic acid amplification reaction is an isothermal reaction.

13. The method of claim 12 , wherein the isothermal reaction is a strand displacement amplification, a multiple displacement amplification, a recombinase polymerase amplification, a helicase dependent amplification, a rolling circle amplification, or a loop mediated isothermal amplification.

14. The method of claim 1 , wherein the halochromic agent is a colorimetric agent or a fluorescent agent.

15. The method of claim 1 , wherein the halochromic agent is phenol red, bromocresol purple, bromothymol blue, neutral red, naphtholphthalein, cresol red, cresolphthalein, or phenolphthalein.

16. The method of claim 1 , wherein the halochromic agent is at a concentration between 50 μM-260 μM.

17. The method of claim 1 , wherein the enzyme is a DNA polymerase.

18. The method of claim 17 , wherein the DNA polymerase is Bst or Taq.

19. The method of claim 1 , wherein the enzyme is a reverse transcriptase, an RNA polymerase, an RNase, a helicase, a recombinase, a ligase, a restriction endonuclease, a TAQ polymerase, or a single-strand binding protein.

20. The method of claim 1 , wherein the enzyme is Bst or Bst 2.0 polymerase, and wherein the halochromic agent is phenol red.

21. The method of claim 1 , wherein the reaction mix further comprises a base.

22. The method of claim 21 , wherein the base is sodium hydroxide or potassium hydroxide.

23. The method of claim 1 , wherein the reaction mix further comprises an acid.

24. The method of claim 23 , wherein the acid is hydrochloric acid or sulfuric acid.

25. The method of claim 1 , wherein the reaction mix further comprises at least one of: dNTPs, primers, and a monovalent cation.

26. The method of claim 25 , wherein the monovalent cation is ammonium, quarternary ammonium, or potassium.

27. The method of claim 1 , wherein the contacting of the sample with the reaction mix offsets the starting pH of the reaction mix by less than 0.1 pH units prior to commencement of the nucleic acid amplification reaction.

28. The method of claim 1 , wherein the starting pH of the reaction mix is between pH 6 and pH 10.

29. The method of claim 28 , wherein the starting pH of the reaction mix is between pH 7.5 and pH 8.8.

30. The method of claim 28 , wherein the starting pH of the reaction mix is between pH 8 and pH 8.8.

31. The method of claim 1 , wherein the detectable colorimetric change is quantifiable at a cell path length of 50 μm.

32. The method of claim 1 , wherein the reaction mix further comprises a second halochromic agent.

33. The method of claim 32 , wherein the halochromic agent is phenol red and wherein the second halochromic agent is bromothymol blue.

34. The method of claim 32 , wherein the halochromic agent is cresol red and wherein the second halochromic agent is bromothymol blue.

35. The method of claim 1 , wherein the nucleic acid amplification reaction product is DNA or RNA.

36. The method of claim 1 , wherein the nucleic acid template molecule is DNA or RNA.

37. The method of claim 1 , wherein the sample contributes between 4.8×10 −9 and 4.8×10 −18 hydronium ion equivalents to the reaction mix, per 10 μl reaction mix.

38. The method of claim 1 , wherein the sample is diluted between 5-40% upon contacting the sample with the reaction mix.

39. The method of claim 1 , wherein the sample is at a pH between pH 3 and pH 11.

40. The method of claim 1 , wherein the detectable colorimetric change is detected based on an imaging of the reaction mix.

41. The method of claim 40 , wherein the imaging comprises determining a change in contrast of an image of the reaction mix.

42. The method of claim 40 , wherein the imaging comprises determining a change in HSV or RGB values of an image of the reaction mix.

43. A kit for colorimetric detection of a nucleic acid amplification reaction product, the kit comprising:

a buffer having a buffering capacity equivalent to Tris buffer at a concentration between 1.5 mM-19 mM in a solution having a starting pH of 8.0;

an enzyme for catalyzing a nucleic acid amplification reaction;

a halochromic agent; and

instructions for use comprising instructions for contacting a sample with a reaction mix comprising the buffer and the enzyme and the halochromic agent under conditions that a nucleic acid amplification reaction occurs and produces a nucleic acid amplification reaction product if the sample contains a target nucleic acid template molecule, the reaction mix, and wherein if the target nucleic acid template molecule is present, the nucleic acid amplification reaction changes a starting pH of the reaction mix to cause a detectable colorimetric change of the halochromic agent, thereby indicating the presence of the target nucleic acid, and if the target nucleic acid template molecule is not present, the nucleic acid amplification reaction does not generate an adequate number of protons to sufficiently change the starting pH of the reaction mix to cause a detectable colorimetric change of the halochromic agent, thereby indicating that the nucleic acid amplification reaction product has not been produced.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 3, 2023
From: LUCIRA HEALTH, INC.
To: PFIZER INC.
Reel/Frame 064784/0948 →
CHANGE OF NAME Recorded May 14, 2019
From: DIASSESS INC.
To: LUCIRA HEALTH, INC.
Reel/Frame 049179/0068 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 2, 2017
From: MITRA, DEBKISHORE; DIMOV, IVAN KRASTEV; WALDEISEN, JOHN ROBERT
To: DIASSESS INC.
Reel/Frame 041162/0287 →
Continuity (2)
Provisional Application 61983687 · Apr 24, 2014
Related Publication 20170044599A1 · Feb 16, 2017
Cited By (3)
US 1,063,100 US 12,208,389 US 12,582,992